Fulgent Genetics Inc (FLGT)

Return on assets (ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands -42,708 -164,969 -163,428 -165,947 -168,334 -64,261 -49,811 -27,045 142,783 271,198 392,377 460,652 507,364 569,332 493,448 416,957 214,310 47,707 2,531 -459
Total assets US$ in thousands 1,219,960 1,233,760 1,232,240 1,229,880 1,273,110 1,358,400 1,354,580 1,376,770 1,386,050 1,405,780 1,461,660 1,465,590 1,278,720 1,204,670 1,049,860 999,083 700,461 247,311 95,915 89,325
ROA -3.50% -13.37% -13.26% -13.49% -13.22% -4.73% -3.68% -1.96% 10.30% 19.29% 26.84% 31.43% 39.68% 47.26% 47.00% 41.73% 30.60% 19.29% 2.64% -0.51%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $-42,708K ÷ $1,219,960K
= -3.50%

Fulgent Genetics Inc's return on assets (ROA) has shown significant fluctuations over the past few years based on the provided data.

The ROA started at a negative figure of -0.51% as of March 31, 2020, indicating that the company was not utilizing its assets efficiently to generate profits. However, the ROA turned positive in the subsequent quarters, reaching a peak of 47.26% on September 30, 2021.

From December 31, 2021, onwards, the ROA began to decline steadily, dropping to 10.30% by the end of December 31, 2022, before entering negative territory in the following periods. The company experienced a significant decline in ROA, falling to -13.49% by March 31, 2024.

Overall, Fulgent Genetics Inc's ROA has been volatile, indicating fluctuations in the company's profitability relative to its total assets. The declining trend in recent periods suggests potential inefficiencies in asset utilization or decreasing profitability. Further analysis of the company's financial performance and operational strategies may be needed to address these fluctuations and improve ROA in the future.